Pfizer Inc.
Narrative signal
Pfizer Inc.’s revenue growth stands at 6.8% for Dec 2024. Year-over-year, the metric shifted by +47.5 pts, translating into a +116.83% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
Valuation Signals
Track how the market prices earnings, book value, and operating cash flow for rapid context on relative multiples.
Price-to-Earnings Ratio
18.7x
Price-to-Sales Ratio
2.4x
Price-to-Book Ratio
1.7x
EV / EBITDA
11.9x
Dividend Yield
6.3%
Profitability Pulse
Follow margin structure and return ratios that benchmark execution quality and capital efficiency.
Growth Momentum
Gauge the trajectory of revenue, earnings, and free cash flow expansion to understand durability.
Cash & Balance Sheet
Monitor liquidity, leverage, and free cash flow capacity that underpin resilience across cycles.
AlphaPilot quick take
• Pfizer Inc. trades at $26.03 with a market footprint around $148.0B.
• Operating within Healthcare — Drug Manufacturers - General offers instant peer context.
• Dashboard highlight: revenue growth at 6.8%, refreshed from the live fundamentals feed.
• Pivot into AlphaPilot deep dives to benchmark valuation, execution, and resilience.
Company profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Pfizer Inc. (PFE) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Pfizer Inc. (PFE) stock price today?
Pfizer Inc. (PFE) trades near $26.03 as of Dec 5, 2025, 9:00 PM. Quotes refresh throughout the trading day in USD via Financial Modeling Prep, which powers the AlphaPilot dashboard.
What is Pfizer Inc.'s market capitalization?
Pfizer Inc.'s equity is valued around $148.0B, based on the latest share price multiplied by shares outstanding reported to Financial Modeling Prep.
What is the 52-week range for Pfizer Inc.?
Pfizer Inc.'s 52-week range runs from $20.92 — $27.69. Comparing the current price to this band helps visualize positioning versus the past year's highs and lows.
How active is trading in Pfizer Inc. stock?
Pfizer Inc. most recently moved about 47M shares. Elevated volume often signals strong investor interest or fresh catalysts.
Does Pfizer Inc. pay a dividend?
Pfizer Inc. currently yields roughly 6.3%. Dividend yield divides the last 12 months of payouts by the latest share price, providing a quick income snapshot.
What is Pfizer Inc.'s intraday trading range?
Pfizer Inc. has traded between $25.64 — $26.12 so far today. Monitoring the intraday span highlights short-term volatility relative to the longer 52-week range.
Where does the Pfizer Inc. stock data come from?
AlphaPilot sources quotes, fundamentals, and intraday chart data for Pfizer Inc. from the Financial Modeling Prep institutional API. The summary page blends live pricing with fundamentals that refresh after every earnings release or regulatory filing.